Compare Stocks: TMDX, GKOS, PODD, and TFX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$179.02 +1.3%	$171.35	$73.16 ▼ $191.62	$10.55B	0.69	1.00 million shs	961,189 shs
PODD Insulet	$149.01 +0.6%	$140.58	$126.40 ▼ $354.88	$10.33B	1.11	1.64 million shs	802,949 shs
TFX Teleflex	$136.50 -0.1%	$130.94	$100.18 ▼ $145.00	$5.77B	0.83	732,771 shs	505,077 shs
TMDX TransMedics Group	$70.74 -1.8%	$83.92	$60.10 ▼ $156.00	$2.44B	1.94	814,528 shs	789,689 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	0.00%	+8.86%	+15.69%	+16.70%	+134.17%
PODD Insulet	0.00%	+5.61%	+9.74%	-8.73%	-54.74%
TFX Teleflex	0.00%	+4.67%	+13.60%	+3.52%	+2.76%
TMDX TransMedics Group	0.00%	-0.06%	-15.69%	-2.10%	-40.82%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$179.02 +1.3%	$171.35	$73.16 ▼ $191.62	$10.55B	0.69	1.00 million shs	961,189 shs
PODD Insulet	$149.01 +0.6%	$140.58	$126.40 ▼ $354.88	$10.33B	1.11	1.64 million shs	802,949 shs
TFX Teleflex	$136.50 -0.1%	$130.94	$100.18 ▼ $145.00	$5.77B	0.83	732,771 shs	505,077 shs
TMDX TransMedics Group	$70.74 -1.8%	$83.92	$60.10 ▼ $156.00	$2.44B	1.94	814,528 shs	789,689 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	0.00%	+8.86%	+15.69%	+16.70%	+134.17%
PODD Insulet	0.00%	+5.61%	+9.74%	-8.73%	-54.74%
TFX Teleflex	0.00%	+4.67%	+13.60%	+3.52%	+2.76%
TMDX TransMedics Group	0.00%	-0.06%	-15.69%	-2.10%	-40.82%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GKOS Glaukos	2.80	Moderate Buy	$181.43	1.34% Upside
PODD Insulet	2.46	Hold	$186.68	25.28% Upside
TFX Teleflex	2.67	Moderate Buy	$154.40	13.11% Upside
TMDX TransMedics Group	2.33	Hold	$115.60	63.42% Upside

Current Analyst Ratings Breakdown

Latest TMDX, GKOS, PODD, and TFX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/15/2026	GKOS Glaukos	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
10/14/2026	TFX Teleflex	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Hold	$150.00 ➝ $142.00
10/13/2026	GKOS Glaukos	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$190.00
10/13/2026	TMDX TransMedics Group	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$95.00 ➝ $94.00
10/12/2026	PODD Insulet	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$275.00 ➝ $190.00
10/12/2026	GKOS Glaukos	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$202.00 ➝ $205.00
10/7/2026	PODD Insulet	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold
10/7/2026	TMDX TransMedics Group	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Overweight	$120.00
10/6/2026	PODD Insulet	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Underweight ➝ Equal Weight	$150.00
9/28/2026	TFX Teleflex	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Neutral ➝ Buy	$145.00 ➝ $158.00
9/24/2026	TFX Teleflex	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy

(Data available from 10/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GKOS Glaukos	$507.44M	20.81	N/A	N/A	$11.42 per share	15.68
PODD Insulet	$2.71B	3.82	$6.32 per share	23.57	$21.54 per share	6.92
TFX Teleflex	$1.99B	2.90	$11.21 per share	12.18	$70.71 per share	1.93
TMDX TransMedics Group	$605.49M	4.04	$3.93 per share	18.01	$13.79 per share	5.13

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GKOS Glaukos	-$187.69M	-$3.25	N/A	325.50	N/A	-30.68%	-6.37%	-4.78%	10/28/2026 (Confirmed)
PODD Insulet	$247.10M	$5.35	27.85	19.33	1.17	12.29%	29.29%	13.31%	11/4/2026 (Confirmed)
TFX Teleflex	-$905.64M	-$23.29	15.58	12.53	0.91	-39.67%	11.93%	5.44%	11/5/2026 (Estimated)
TMDX TransMedics Group	$190.29M	$3.89	35.91	31.30	0.97	22.69%	15.88%	5.95%	11/5/2026 (Estimated)

Latest TMDX, GKOS, PODD, and TFX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	TFX Teleflex	$1.90	N/A	N/A	N/A	$565.51 million	N/A
11/5/2026	Q3 2026	TMDX TransMedics Group	$0.2976	N/A	N/A	N/A	$178.06 million	N/A
11/4/2026	Q3 2026	PODD Insulet	$1.59	N/A	N/A	N/A	$832.71 million	N/A
10/28/2026	Q3 2026	GKOS Glaukos	-$0.0964	N/A	N/A	N/A	$168.04 million	N/A
8/6/2026	Q2 2026	TFX Teleflex	$1.28	$1.76	+$0.48	$2.28	$559.59 million	$570.33 million
8/5/2026	Q2 2026	PODD Insulet	$1.47	$1.66	+$0.19	$1.37	$787.39 million	$801.70 million
8/4/2026	Q2 2026	TMDX TransMedics Group	$0.4955	$0.44	-$0.0555	$0.41	$184.00 million	$189.95 million
7/29/2026	Q2 2026	GKOS Glaukos	-$0.2105	-$0.14	+$0.0705	-$0.31	$150.93 million	$185.61 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
TFX Teleflex	$1.36	1.00%	N/A	N/A	N/A
TMDX TransMedics Group	N/A	N/A	N/A	N/A	N/A

Latest TMDX, GKOS, PODD, and TFX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	TFX Teleflex	quarterly	$0.34	0.99%	8/14/2026	8/14/2026	9/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GKOS Glaukos	0.10	5.04	4.46
PODD Insulet	0.65	2.48	1.83
TFX Teleflex	0.94	2.60	2.12
TMDX TransMedics Group	1.62	6.62	6.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GKOS Glaukos	99.04%
PODD Insulet	N/A
TFX Teleflex	95.62%
TMDX TransMedics Group	99.67%

Insider Ownership

Company	Insider Ownership
GKOS Glaukos	5.90%
PODD Insulet	0.36%
TFX Teleflex	0.70%
TMDX TransMedics Group	6.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GKOS Glaukos	1,094	58.98 million	55.50 million	Optionable
PODD Insulet	5,400	69.35 million	69.10 million	Optionable
TFX Teleflex	15,500	42.37 million	42.08 million	Optionable
TMDX TransMedics Group	898	34.56 million	32.18 million	Optionable

TMDX, GKOS, PODD, and TFX Headlines

Recent News About These Companies

TransMedics to Report Third Quarter 2026 Financial Results on November 5, 2026

October 22 at 4:05 PM | prnewswire.com

TransMedics Group (NASDAQ:TMDX) & QuidelOrtho (NASDAQ:QDEL) Financial Comparison

October 22 at 2:15 AM | americanbankingnews.com

TransMedics Group Inc TMDX

October 20, 2026 | morningstar.comM

Stifel holds TransMedics Group stock at USD 65.00 amid competition

October 20, 2026 | ad-hoc-news.deA

TransMedics Group - Some Hiccups In The Long Term Growth Story

October 20, 2026 | seekingalpha.com

TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking a 39% Upside Potential in Healthcare Innovation

October 19, 2026 | directorstalkinterviews.com

Stifel holds TransMedics stock at Hold amid competition concerns

October 18, 2026 | ad-hoc-news.deA

17,734 Shares in TransMedics Group, Inc. $TMDX Purchased by Annex Advisory Services LLC

October 18, 2026 | marketbeat.com

TransMedics Group (TMDX) Stock Looks Undervalued On Current Earnings

October 17, 2026 | finance.yahoo.com

TransMedics Group (NASDAQ:TMDX) Shares Down 5.7% - Here's What Happened

October 16, 2026 | marketbeat.com

iRhythm Technologies (NASDAQ:IRTC) versus TransMedics Group (NASDAQ:TMDX) Head-To-Head Comparison

October 15, 2026 | americanbankingnews.com

Canaccord Genuity Group Issues Pessimistic Forecast for TransMedics Group (NASDAQ:TMDX) Stock Price

October 15, 2026 | americanbankingnews.com

TransMedics Group (NASDAQ:TMDX) Stock Gets Price Target Trim from Canaccord Genuity Group

October 13, 2026 | marketbeat.com

Barclays initiates coverage of TransMedics Group at overweight

October 8, 2026 | msn.com

TransMedics Group consensus price target rises 10.91% to MX$1,984.96

October 8, 2026 | msn.com

41,109 TransMedics Group, Inc. $TMDX Shares Sold by Zevenbergen Capital Investments LLC

October 8, 2026 | marketbeat.com

TransMedics Group stock gets USD 120.00 target from Barclays

October 8, 2026 | ad-hoc-news.deA

TransMedics Group (NASDAQ:TMDX) Shares Climb 4.2% - Time to Buy?

October 7, 2026 | marketbeat.com

TransMedics Group (NASDAQ:TMDX) Now Covered by Analysts at Barclays

October 7, 2026 | marketbeat.com

TransMedics Group, Inc. $TMDX Shares Purchased by Congress Asset Management Co.

October 7, 2026 | marketbeat.com

TransMedics Group, Inc. (NASDAQ:TMDX) Stock Has Average Price Target of $121.10 According to Brokerages

October 5, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, GKOS, PODD, and TFX Company Descriptions

Glaukos NYSE:GKOS

$179.02 +2.33 (+1.32%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$178.88 -0.14 (-0.08%)

As of 10/23/2026 07:30 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Insulet NASDAQ:PODD

$149.01 +0.89 (+0.60%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$147.37 -1.64 (-1.10%)

As of 10/23/2026 07:40 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Teleflex NYSE:TFX

$136.50 -0.08 (-0.06%)

Closing price 10/23/2026 03:59 PM Eastern

Extended Trading

$136.33 -0.17 (-0.12%)

As of 10/23/2026 07:30 PM Eastern

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TransMedics Group NASDAQ:TMDX

$70.74 -1.32 (-1.83%)

Closing price 10/23/2026 04:00 PM Eastern

Extended Trading

$69.94 -0.80 (-1.13%)

As of 10/23/2026 07:56 PM Eastern

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMDX, GKOS, PODD, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMDX, GKOS, PODD, and TFX Earnings

Compare Dividends

Latest TMDX, GKOS, PODD, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMDX, GKOS, PODD, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, GKOS, PODD, and TFX Company Descriptions

Glaukos NYSE:GKOS

Insulet NASDAQ:PODD

Teleflex NYSE:TFX

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest TMDX, GKOS, PODD, and TFX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest TMDX, GKOS, PODD, and TFX Earnings

Compare Dividends

Latest TMDX, GKOS, PODD, and TFX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

TMDX, GKOS, PODD, and TFX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMDX, GKOS, PODD, and TFX Company Descriptions

Glaukos NYSE:GKOS

Insulet NASDAQ:PODD

Teleflex NYSE:TFX

TransMedics Group NASDAQ:TMDX

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools